Safety and effectiveness of up to 3 years’ bulevirtide monotherapy in patients with HDV-related cirrhosis
Alessandro Loglio, Péter Ferenci, Sara Uceda Renteria, C Tham, Caroline Scholtès, Heidemarie Holzmann, Florian van Bömmel, Marta Borghi, Riccardo Perbellini, Alessandro Rimondi, Elisa Farina, Elena Trombetta, Maria Manunta, Laura Porretti, Daniele Prati, Ferruccio Ceriotti, Fabien Zoulim, Antonio Bertoletti, Pietro Lampertico
Topics & Concepts
MedicineCirrhosisHBsAgGastroenterologyInternal medicineAsymptomaticHepatitis D virusHepatitis DLiver functionHepatocellular carcinomaHBeAgHepatitis B virusImmunologyVirusHepatitis B Virus StudiesHepatitis C virus researchHepatitis Viruses Studies and Epidemiology